Eye doctor explains rare vision loss condition linked to popular GLP-1 medications
NYU Langone’s Dr. Douglas Lazzaro weighs the potential connection between GLP-1 use and NAION, saying the overall health benefits can outweigh the relatively uncommon ophthalmic complication for many people.
